| Similar Articles |
|---|
 |
Bio-IT World
Dec 2006/Jan 2007
Allison Proffitt |
'An Unfortunate Storm': Tripos CEO Discusses Company Future Tripos announced that it has successfully sold its Discovery Informatics business to Vector Capital. Despite the company's difficulties, including a collapsed share price, president and CEO John McAllister is upbeat about the company's future.   |
Bio-IT World
September 2006
Mike May |
Working Out the Flow Better management of workflow issues in biotech and pharma could change fundamental aspects of these sciences in the near future. |
Bio-IT World
October 2005 |
News Blast Blue Gene Challenge... Speeding Workflows... Inside Informatics... Adding Analysis... |
Bio-IT World
March 8, 2005
Kevin Davies |
InforSense Approach to Data Sharing CEO Yike Guo discusses Shanghai's giant grid computing project to link scientists. |
Bio-IT World
September 2005 |
New Products Tripos Brings Informatics to the Bench... More Choice with Midsized Storage System... More Intelligence Added to Symyx Lab Notebook... Dell Adds Dual-Core to PowerEdge Servers... |
Bio-IT World
November 2005 |
Bridges and Boundaries in Drug Discovery Research Good communication, blurring cultural boundaries, and strong project governance may be as, if not more, important as sweeping technology solutions when it comes to converging discovery and IT and expediting drug development. |
Bio-IT World
October 14, 2004
Salvatore Salamone |
Riding the New Wave New offerings from Accelrys, LION bioscience, MDL, Synthematix, and Tripos may be the crest of a new wave of software designed to meet increasing demand to incorporate chemoinformatics into the drug discovery process. |
Bio-IT World
November 2006
Kevin Davies |
Building a Bridge Over Pharma with IT More than 100 enthusiastic delegates bridging the full breadth of the drug development pipeline gathered recently for the second annual Bridging Pharma and IT conference. Here are some highlights. |
Bio-IT World
October 9, 2002
Richard Dweck |
The Ups and Downs of Informatics Outsourcing As much as the industry endures shifts and volatility, new informatics technologies are still essential for more efficient drug discovery and better drugs. The advantages that can be gained justify enduring the upheaval. |
Bio-IT World
February 2006 |
News Blast Trimming at Tripos... RNAi Settlement... Personalized Push... |
Pharmaceutical Executive
July 1, 2005
Zaborowski, Hammer & Lawler |
Informatics Rules How global computer systems helped far-flung research centers at Roche work together |
Bio-IT World
September 2005
Kevin Davies |
Bringing Good Things to Informatics In interview with Nick Giannasi, Head of Informatics for GE Healthcare's Bio-Sciences division on how the company is shedding light on data integration in discovery and clinical trials. |
The Motley Fool
November 15, 2006
Alyce Lomax |
A Very Complicated Discovery Complexity rules in Discovery Holding's third-quarter results. Investors, take note. |
Bio-IT World
April 2006
John Russell |
Pfizer's Pursuit of Technology Can this $50-billion-plus, 115,000-employee behemoth succeed where other pharma giants have failed and successfully institutionalize the effort to find and develop critical new technology? Should it even try? |
Information Today
February 26, 2015 |
NISO Releases White Paper on the Future of Library Resource Discovery NISO (National Information Standards Organization) published a white paper, "The Future of Library Resource Discovery," which summarizes the current discovery environment. |
Bio-IT World
August 2005
Johan Bostrom |
Agilent Acquisitions Bolster Portfolio of Products A string of acquisitions is helping Agilent Technologies establish itself as a major player in informatics for analytical laboratories, and its expanding product portfolio has made it a serious player in laboratory analysis automation and software integration. |
Bio-IT World
February 11, 2005
Salvatore Salamone |
Make Room for Microsoft High-performance computing: the 800-lb. Gorilla of desktop computing plans aggressive push into life science clusters. |
The Motley Fool
May 21, 2007
Tim Beyers |
Retail a Deadly Catch for Discovery The Discovery Channel operator will close 103 stores. |
Bio-IT World
August 13, 2002
Russell & Dodge |
Necessary Liaisons: Making Standards Work Caroline Kovac, IBM Corp.'s general manager for life sciences, talks about the need for standards and her take on the troubled informatics world. |
CIO
October 15, 2001
Stephanie Overby |
Drug Companies on speed The marriage of IT and medical research may be just what traditional pharmaceutical companies need to survive in an increasingly competitive field. Learn how IT is bringing the pharmaceutical industry into the information age... |
Bio-IT World
April 2007
Vicki Glaser |
Software Solutions for Medicinal Chemistry Driven by advances in chemical synthesis, instrumentation, and high-throughput and high-content screening technology, medicinal chemistry's transition from an art to a science is benefiting from a wealth of new software products, spanning both bio- and cheminformatics. |
Bio-IT World
March 10, 2003
Mark D. Uehling |
Technology Overload Inundated with new IT tools and mountains of data, the pharmaceutical industry struggles to pull it all together. |
